HistoSonics
PrivateLast Round
VC Round
Jun 22, 2026
Est. Valuation
$3.75B
Total Funding Raised
$465.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
HistoSonics is a medical technology company that develops a non-invasive, robotically assisted sonic beam therapy platform for liquefying and destroying targeted tissues at a sub-cellular level.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HistoSonics Comparables
Compare HistoSonics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insightec | 77% | |
| Galvanize Therapeutics | 76% | |
| SONIRE Therapeutics Inc. | 76% |
HistoSonics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 22, 2026 | ||||
| Private Equity | Oct 16, 2025 | ||||
| Buyout/LBO | Aug 7, 2025 | ||||
| IPO | Jan 27, 2025 | ||||
| Series D | Aug 15, 2024 | ||||
VC Round | Dec 13, 2022 |
Key People
Founding team and executive leadership
HistoSonics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Early Stage Partners | Buyout/LBO, Series B, Series A |
| Amzak Health | Buyout/LBO, Series D |
| Yonjin Capital | Buyout/LBO, Series D, VC Round, Series C Extension |
| Founders Fund | Private Equity |
| Hatteras Venture Partners | Buyout/LBO, Series B, Series A |
| Bezos Expeditions | Buyout/LBO, Private Equity |
| State of Wisconsin Investment Board | Buyout/LBO, Series D, Series C Extension, VC Round, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Raised $3.75B post-money valuation with Yosemite and Reed Paul Jobs.
- May 4, 2026
Keynote speaker at DeviceTalks Minnesota on May 4, 2026.
Recent news
Latest coverage and updates
- has_valuationSep 23, 2026
HistoSonics, Inc. had valuation of $2.25B on Jul 1st '25.
- is_developingJul 13, 2026
HistoSonics, Inc. is developing non-invasive platform and proprietary sonic beam therapy on Jul 13th '26.
- is_developingJul 6, 2026
HistoSonics, Inc. is developing medical device platform that mechanically destroys tumors non-invasively using focused ultrasound.
HistoSonics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HistoSonics's valuation, stock price, and market status.
Is HistoSonics a public or private company?
HistoSonics is a private company.
What is the current stock price of HistoSonics?
HistoSonics is a private company with no public stock price. No recent secondary market data is available.
How much is HistoSonics worth (valuation)?
HistoSonics's valuation is estimated at $3.8B based on funding round data.
Can I buy HistoSonics stock?
HistoSonics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HistoSonics's last funding round?
HistoSonics's most recent funding round was Growth Equity on June 22, 2026.
Who are the main investors in HistoSonics?
Key investors in HistoSonics include Yonjin Capital, Bezos Expeditions, K5 Global, Wellington Management, Johnson & Johnson Innovation - JJDC, Inc..
Will HistoSonics IPO soon?
No public IPO plans have been announced for HistoSonics.
How can I track HistoSonics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HistoSonics's secondary market activity and sign up for updates.